-
1 Comment
A&T Corporation is currently in a long term uptrend where the price is trading 14.2% above its 200 day moving average.
From a valuation standpoint, the stock is 98.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.1.
A&T Corporation's total revenue sank by 35.0% to $2B since the same quarter in the previous year.
Its net income has dropped by 138.8% to $-102M since the same quarter in the previous year.
Based on the above factors, A&T Corporation gets an overall score of 2/5.
| Sector | Healthcare |
|---|---|
| Industry | Medical Devices |
| Exchange | TSE |
| CurrencyCode | JPY |
| ISIN | JP3160680009 |
| Market Cap | 11B |
|---|---|
| Beta | 0.65 |
| PE Ratio | 38.4 |
| Target Price | 1000 |
| Dividend Yield | 0.5% |
A&T Corporation develops, manufactures, and markets products in the fields of chemicals, analyzers, computers, and lab-logistics in Japan and internationally. It offers laboratory automation systems and managed pre-analysis modules; coagulation, electrolyte, and glucose analyzers; reagents for immunoassays; and CLINILAN, a laboratory resource planning system. The company was founded in 1978 and is headquartered in Yokohama, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 6722.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
